Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Recent data from the ATTAIN-MAINTAIN trial showed that patients transitioning to orforglipron after injectable GLP-1 therapy maintained their weight loss with minimal regain (approximately 0.9 kg after semaglutide transition), suggesting that oral maintenance strategies could minimize the lean mass depletion seen with prolonged high-dose injectable therapy
The same concepts also apply to peptides and proteins, each of which will have a pI value that is influenced by the characteristics of its side chains
For specific drug comparisons, see our guides on compounded semaglutide vs
Through December 31, 2026, Lilly is offering eligible self-pay patients a 1-month supply of Zepbound 7.5 mg, 10 mg, 12.5 mg, and 15 mg dose KwikPens (or vials) for $449 each
Despite Eli Lillys efforts to meet demand through increased production capacity, localized shortages persist due to distribution limitations and allocation issues at pharmacies
Available at: 2 HolstJJ
US$ 20.43
US$ 22.87
US$ 22.83
